Insmed (INSM) Non-Current Debt (2012 - 2026)

Insmed's (INSM) quarterly Non-Current Debt came in at $546.8 million in Q1 2026, down 50.52% year-on-year from $1.1 billion in Q1 2025, and up 1.07% quarter-over-quarter from $541.0 million in Q4 2025.

Insmed (INSM) Non-Current Debt (2012 - 2026) Analysis & Trends

Insmed's Non-Current Debt history runs 15 years deep, the most recent figure standing at $546.8 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 50.52% year-over-year to $546.8 million in Q1 2026; TTM through Mar 2026 was $546.8 million, a 50.52% decrease from a year earlier, with the FY2025 full-year figure at $541.0 million, down 50.97% from the prior year.
  • Non-Current Debt advanced to $546.8 million in Q1 2026 per INSM's latest filing, from $541.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.2 billion in Q3 2023 and bottomed at $538.5 million in Q2 2025.
  • The 5-year median for Non-Current Debt is $946.8 million (2024), against an average of $903.9 million.
  • Across the five-year window, Non-Current Debt jumped 121.25% in 2022 and plunged 50.97% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $1.1 billion in 2022, then climbed by 2.67% to $1.2 billion in 2023, then dropped by 4.49% to $1.1 billion in 2024, then plunged by 50.97% to $541.0 million in 2025, then advanced by 1.07% to $546.8 million in 2026.
  • Per Business Quant, the three latest INSM Non-Current Debt figures stand at $546.8 million (Q1 2026), $541.0 million (Q4 2025), and $539.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 546.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 546.77 Mn
Dec 31, 2025 540.96 Mn
Sep 30, 2025 539.72 Mn
Jun 30, 2025 538.51 Mn
Mar 31, 2025 1.11 Bn
Dec 31, 2024 1.10 Bn
Sep 30, 2024 971.76 Mn
Jun 30, 2024 946.83 Mn
Mar 31, 2024 939.08 Mn
Dec 31, 2023 1.16 Bn
Sep 30, 2023 1.17 Bn
Jun 30, 2023 1.17 Bn
Mar 31, 2023 1.13 Bn
Dec 31, 2022 1.13 Bn
Sep 30, 2022 784.80 Mn
Jun 30, 2022 800.00 Mn
Mar 31, 2022 800.00 Mn
Dec 31, 2021 566.59 Mn
Sep 30, 2021 557.60 Mn
Jun 30, 2021 548.75 Mn